Daily Health Headlines

Antibodies May Hold Key to HIV Suppression

👤by Steven Reinberg 0 comments 🕔Thursday, November 10th, 2016

WEDNESDAY, Nov. 9, 2016 (HealthDay News) -- Antibodies may keep the HIV virus in check and one day let patients stop taking antiretroviral drugs, two new preliminary trials suggest.

Researchers tried to quell HIV in 23 patients with infusions of an anti-HIV antibody known as VRC01. The antibody was safe and repressed blood levels of HIV for a short time before the virus reappeared, the researchers said. HIV is the virus that can lead to AIDS.

"We were not expecting that we were going to see a prolonged repression, because it was only a single antibody," said co-study author Dr. Anthony Fauci, director of the U.S. National Institute of Allergy and Infectious Diseases.

The next phase is to infuse two or three antibodies intermittently, and see if antiretroviral drugs can be withdrawn permanently, he explained.

After regular intravenous infusions of VRC01, participants in the U.S. National Institutes of Health and the AIDS Clinical Trials Group studies saw the virus reappear in the blood, called viral rebound, at an average of 39 and 28 days, respectively, after antiretroviral therapy was stopped.

Usually, HIV rebounds within about two weeks after stopping therapy, the researchers noted. These results indicate the antibody may have had a modest effect on temporarily controlling HIV, Fauci said.

"It is the very early stage of a new approach to suppressing the virus," he explained.

If this approach is successful, the possible benefit to patients is that they could stop taking antiretroviral drugs altogether, Fauci said.

"Some patients can't tolerate antiretroviral drugs or they have a virus that doesn't do very well with antiretroviral drugs, and many patients are just tired of taking a drug every day and some would say, 'I'd rather get an infusion every few weeks,' " he said.

Fauci said trials using two antibodies should start in the next couple of months.

"It's possible that we could get an antibody that hangs around for a long time and you would only have to infuse it every several months," he added.

For one study, patients were given infusions of VRC01 before they stopped antiretroviral therapy. Additional infusions were given at two and four weeks after halting antiretroviral therapy and then monthly for up to six months.

In a second trial, researchers at the University of Pennsylvania and the University of Alabama gave patients VRC01 infusions one week before stopping antiretroviral therapy and then every three weeks for up to three doses.

The results of the studies were published online Nov. 9 in the New England Journal of Medicine.

One HIV expert welcomed the results.

"These are very early trials so they're mostly trying to show safety, and they certainly did show that the antibody was safe," said Dr. David Rosenthal, medical director of the Center for Young Adult, Adolescent and Pediatric HIV at Northwell Health in Great Neck, N.Y.

"The effectiveness of the therapy is something we are going to have to see in other trials. That will give us a better idea if it is effective and how often it needs to be given," he said. "It will probably take a cocktail of different antibodies to prevent the virus from returning.

"Cure research is continuing to progress," Rosenthal said. "It's not around the corner, but this may give patients some hope. In addition, this approach can help individualize therapy."

Article Credits / Source

Steven Reinberg / HealthDay

Steven Reinberg wrote this story for HealthDay. HealthDay provides up to the minute breaking health news. Click here to view this full article from HealthDay.

SOURCES: Anthony Fauci, M.D., director, U.S. National Institute of Allergy and Infectious Diseases; David Rosenthal, D.O., Ph.D., medical director, Center for Young Adult, Adolescent and Pediatric HIV, and attending allergy/immunology physician, Northwell Health, Great Neck, N.Y.; Nov. 9, 1026, New England Journal of Medicine, online

View More Articles From Steven Reinberg 🌎View Article Website

Sponsored Product

Lunar Sleep for $1.95

Lunar Sleep for $1.95

People who have trouble sleeping typically have low levels of melatonin, so melatonin supplements seem like a logical fix for insomnia. There is a high demand for sleep aids, especially in the U.S. The National Health Interview Survey done in 2002, and again in 2007, found 1.6 million US adults were using complementary and alternative sleep aids for insomnia. Lunar Sleep was a top choice. Use Promo Code: Sleep2014 and only pay $1.95 S&H.

Get Lunar Sleep for $1.95

More HIV Articles

Drug Combo Shows Early Promise for Remission of HIV

Drug Combo Shows Early Promise for Remission of HIV0

THURSDAY, Nov. 10, 2016 (HealthDay News) -- Animal research with an experimental two-drug therapy could hold clues for creating long-term HIV remission in people living with the virus, a new report says. The goal: to free patients from the need ...

Experimental Medicine Might Rescue People With Drug-Resistant HIV

Experimental Medicine Might Rescue People With Drug-Resistant HIV0

FRIDAY, Oct. 28, 2016 (HealthDay News) -- Researchers report that a new medication might revolutionize the treatment of HIV patients who don't respond to existing drugs. The intravenous drug, known as ibalizumab, is given every two weeks. It's ...

Study Discounts Myth of 'Patient Zero' in U.S. AIDS Crisis

Study Discounts Myth of 'Patient Zero' in U.S. AIDS Crisis0

WEDNESDAY, Oct. 26, 2016 (HealthDay News) -- Using genetic analyses of 40-year-old blood samples, scientists have arrived at a clearer understanding of the introduction and spread in North America of the virus that causes AIDS. One myth already ...

HIV May Hide in Tissues, Even After Treatment

HIV May Hide in Tissues, Even After Treatment0

WEDNESDAY, Oct. 26, 2016 (HealthDay News) -- HIV patients who've been treated with antiretroviral drugs still have the AIDS-causing virus in their tissues, a new study suggests. Treatment with antiretrovirals eliminates detectable levels of HIV ...

Monkey Study Hints at Drug-Free Suppression of HIV

Monkey Study Hints at Drug-Free Suppression of HIV0

THURSDAY, Oct. 13, 2016 (HealthDay News) -- Scientists may have found a way to suppress an HIV-like infection in monkeys, without the need for ongoing drug therapy. The researchers added antibody therapy to standard drug treatment given to ...

View More HIV Articles

0 Comments

Write a Comment

Your email address will not be published. Required fields are marked *

Our Mailing List

Subscribe to our mailing list to get the latest health news as it breaks!

Your information will not be shared with anyone!